United Kingdom Ulcerative Colitis Market 規模およびシェア分析 - 成長トレンドおよび予測 (2024 - 2031)

United Kingdom Ulcerative Colitis Market is Segmented By Drug Type (Anti-Inflammatory Drugs, Anti-TNF biologics, Immuno-suppressants, Calcineurin Inhibitors, and Others), By Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis), By Dosage Form (Parenteral and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD million) for the above-mentioned segments.

Competitive overview of United Kingdom Ulcerative Colitis Market

英国潰瘍性大腸炎市場で動作する主要なプレーヤーには、AbbVie Inc.(Allergan, Inc.)、Merck & Co.、Inc.、Novartis AG、Bausch Health Companies Inc.、ジョンソン&ジョンソン、Abbott、COSMO PHARMACEUTICALS、F. Hoffmann-La Roche Ltd、およびPfizer Inc.などがあります。

United Kingdom Ulcerative Colitis Market Leaders

  • AbbVie Inc.(アレルガン株式会社)
  • マーク&株式会社
  • ノバルティスAG
  • Bausch Health Companies Inc.(バッシュヘルスカンパニー)
  • ジョンソン&ジョンソン
*Disclaimer: Major players are listed in no particular order.

United Kingdom Ulcerative Colitis Market - Competitive Rivalry, 2023

Market Concentration Graph

United Kingdom Ulcerative Colitis Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights